Clinical Drug Experience Knowledgebase

bevacizumab (avastin) (3 trials)

capecitabine (xeloda) (5 trials)

cetuximab (erbitux) (1 trial)

everolimus (zortress) (3 trials)

exemestane (aromasin) (2 trials)

pazopanib (votrient) (1 trial)

docetaxel (taxotere) (1 trial)

fulvestrant (faslodex) (2 trials)

paclitaxel (taxol) (2 trials)

pertuzumab (perjeta) (1 trial)

ribociclib (kisqali) (1 trial)

sorafenib (nexavar) (2 trials)

sunitinib (sutent) (1 trial)

trastuzumab (herceptin) (1 trial)

vinorelbine (navelbine) (4 trials)

anastrozole (arimidex) (1 trial)

buparlisib (1 trial)

letrozole (femara) (1 trial)

oxaliplatin (eloxatin) (1 trial)

palbociclib (ibrance) (1 trial)

panitumumab (vectibix) (1 trial)

tamoxifen (nolvadex) (1 trial)

lapatinib (tykerb) (1 trial)